The Impact of AI Algorithms in Cardiology
Artificial intelligence is changing how we detect heart disease.
Beyond Diagnostics - Extending the Utility of ECG-AI
Anumana is expanding into perioperative cardiac care by developing novel generative AI imaging and visualization technologies. Anumana’s perioperative technology will feature real-time imaging platforms and predictive algorithms for common interventions under structural heart, interventional cardiology, and electrophysiology procedures.
Early Detection is Key -
Yet Diagnosis Often Comes Too Late
Despite significant advances in cardiology, early identification of cardiovascular disease remains a global challenge. Many conditions go undetected until symptoms become severe, when interventions are less effective, and patient outcomes are worse.
Anumana is addressing this challenge head-on. We develop and commercialize evidence-based AI solutions designed to enable earlier detection and improve patient care across the entire cardiac care continuum.
ECG-AI® LEF
Anumana is revolutionizing heart care with breakthrough AI that empowers clinicians to identify hidden heart conditions from a simple 12-lead ECG, transforming what’s possible in cardiac diagnosis.
ECG-AI® LEF for the early identification of Low Left Ventricular Ejection Fraction is FDA-cleared and commercially available in the US now.